글로벌 모바일 감마 카메라 시장 – 2023-2030

Global Mobile Gamma Cameras Market - 2023-2030

상품코드MI7815
발행기관DataM Intelligence
발행일2024.01.23
페이지 수187 Pages
포맷PDF + EXCEL
커버리지Global

6,525,00011,775,000

보고서 요약(국문)

개요
글로벌 모바일 감마 카메라 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
모바일 감마 카메라 시스템은 뇌, 심장, 신경계, 유방, 갑상선, 췌장, 신장 등 크고 작은 장기의 기능적 스캔을 생성하는 영상 기술입니다. 모바일 감마 카메라는 인체 또는 장기에 방사성 핵종을 주입한 후 영상 스캔을 통해 방사능을 기록하는 방식으로 신체를 스캔합니다.
모바일 감마 카메라는 완전한 이동형 장치입니다. 환자를 이동시키지 않고도 병상에 설치하여 사용할 수 있습니다. 방사성 동위원소 주입부터 최종 영상 획득까지 단 2분, 총 10분 만에 영상을 획득할 수 있는 3D 모바일 감마 카메라는 응급실에서도 유용한 강력한 진단 도구입니다.

시장 동향: 성장 동인 및 제약 요인
기술 발전의 증가
기술 발전의 증가는 예측 기간 동안 시장 성장을 견인하는 중요한 핵심 동인 중 하나입니다. 향상된 영상 기능을 갖춘 첨단 감마 카메라 시스템의 개발은 휴대용 감마 카메라의 도입을 촉진하고 있습니다.
예를 들어, 2023년 6월, 세락 이미징(Serac Imaging)은 미국에서 휴대용 감마 카메라의 임상 시험을 시작했습니다. 이 카메라는 영국에 본사를 둔 세락 이미징 시스템즈(Serac Imaging Systems)에서 개발한 휴대용 고해상도 하이브리드 감마 광학 카메라로, 현재 미국에서 임상 시험 중입니다. 원래 레스터 대학교에서 X선 ​​천문학 위성용으로 개발한 기술을 기반으로 하는 이 장치는 환자에게 투여된 방사성 동위원소를 방사선으로 촬영하여 신체 기능, 예를 들어 막힘 여부 등에 대한 정보를 제공합니다.
이 카메라의 잠재적 응용 분야로는 뼈, 신장 및 감염 영상, 림프관 영상, 감시 림프절 위치 파악, 갑상선과 같은 소기관 영상 등이 있습니다.

따라서 새로운 의약품은 새로운 가능성을 열어주며, 우리는 새로운 질병을 치료하고 완치할 수 있을지도 모릅니다. 새로운 카메라와 더욱 빠르고 성능이 향상된 검출기를 통해 이미지는 더욱 선명해지고, 영상 획득 속도는 빨라지며, 환자의 방사선 노출량은 감소합니다. 인공지능(AI)은 의료진에게 중요한 도움을 줄 수 있습니다. 또한, 만성 질환 유병률 증가, 모바일 감마 카메라의 도입 확대 등 다양한 요인들이 전 세계 모바일 감마 카메라 시장을 견인하고 있으며, 이러한 요인들은 예측 기간 동안 시장 성장을 더욱 촉진할 것입니다.
시장 동향: 제약 요인
모바일 감마 카메라와 같은 새로운 의료기기 도입은 규제 및 보험금 지급 문제에 직면하여 도입 및 가격 경쟁력에 영향을 미칩니다. 또한, 높은 초기 투자 비용과 지속적인 유지 보수 비용과 같은 비용 제약은 특히 자원이 제한된 환경에서 시장 접근성을 저해하여 이러한 기기의 도입을 제한할 수 있습니다.
세분화 분석
전 세계 모바일 감마 카메라 시장은 제품 유형, 적응증, 최종 사용자 및 지역별로 세분화됩니다.

제품 유형 부문에서 트리플 헤드 모바일 감마 카메라 부문은 모바일 감마 카메라 시장 점유율의 약 43.5%를 차지했습니다.
트리플 헤드 모바일 감마 카메라 부문은 제품 유형 부문에서 약 43.5%를 차지하며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 유형 부문 중 트리플 헤드 모바일 감마 카메라는 우수한 영상 품질, 빠른 영상 해상도, 그리고 비용 효율성 덕분에 시장에서 가장 빠른 성장세를 보이고 있습니다. 이 카메라는 주로 뇌와 심장 SPECT 검사에 사용되며, 의료진과 환자 모두에게 여러 가지 이점을 제공하기 때문에 수요가 높습니다.
또한, 트리플 헤드 모바일 감마 카메라는 세 개의 검출기를 동시에 사용하여 향상된 영상 품질, 빠른 영상 촬영 시간, 그리고 환자 생산성 향상을 제공합니다.

지리적 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 암, 심장병과 같은 만성 질환의 높은 유병률로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 인구 고령화에 따라 이러한 질환을 진단하고 모니터링하는 모바일 감마 카메라와 같은 진단 도구에 대한 수요가 지속적으로 증가하고 있습니다. 또한, 신제품 출시와 향상된 이미지 품질 및 방사선 노출 감소를 포함한 모바일 감마 카메라 기술의 지속적인 발전이 북미 지역의 도입을 촉진하고 있습니다.
예를 들어, 2020년 5월 Digirad는 Ergo 범용 핵의학 카메라와 Cardius SPECT 카메라 라인의 업데이트 버전을 출시한다고 발표했습니다. 이 업그레이드된 카메라는 2019년 한 해 동안 개발되었으며 이번 분기에 미국과 캐나다 시장에서 임상적으로 처음 선보입니다.
COVID-19 영향 분석
신종 코로나바이러스 감염증(COVID-19) 팬데믹으로 인해 전 세계적으로 신장 질환 치료가 크게 감소했습니다. 팬데믹이 절정에 달했을 때, 이식이나 투석과 같은 치료를 받는 신부전 환자 수가 급격히 감소했습니다. 이러한 요인들이 지난 몇 달 동안 모바일 감마 카메라 산업의 꾸준한 성장에 부정적인 영향을 미쳤을 수 있습니다.
시장 세분화
제품 유형별
• 트리플 모바일 감마 카메라
• 더블 모바일 감마 카메라
• 싱글 헤드 모바일 감마 카메라
• 휴대용 모바일 감마 카메라
적응증별
• 심장 영상
• 유방 영상
• 간담도 영상
• 위장관 영상
• 신장 영상
• 뇌 영상
• 기타
최종 사용자별
• 병원
• 외래 수술 센터
• 암 연구 기관
• 전문 클리닉
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Digirad Corporation, DDD-Diagnostic A/S 등이 있습니다. Spectrum Dynamics Medical, MIE America, LabLogic Systems Ltd, Crystal Photonics, Oncovision Inc, GAEDE Medizinsysteme GmbH, Mediso Ltd, GE Healthcare 등이 주요 기업입니다.

주요 개발 사항
 2022년 5월, GE Healthcare는 새로운 모바일 감마 카메라 Discovery NM/CT 570c를 출시했습니다. Discovery NM/CT 570c는 SPECT/CT 영상 기능을 하나의 장치에 결합한 하이브리드 모바일 감마 카메라입니다.
보고서 ​​구매 이유

• 제품 유형, 적응증, 최종 사용자 및 지역별 글로벌 모바일 감마 카메라 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 식별하기 위해

• 모든 세그먼트를 포함한 모바일 감마 카메라 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.
글로벌 모바일 감마 카메라 시장 보고서는 약 77개의 표, 79개의 그림, 187페이지 분량입니다.
2023년 주요 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Mobile Gamma Cameras Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
A mobile gamma camera system is an imaging technique to generate functional scans of small and large organs including brain, cardiac, neurological, breast, thyroid, pancreas and kidney applications. The mobile gamma camera scans the body by using a procedure that follows injecting a radionucleotide in the body or organ and then recording the resulting radioactivity by image scanning.
The Mobile Gamma Camera is a fully mobile unit. It can be positioned and used at the hospital bed without moving the patient. With an acquisition time of just 2 minutes and a total examination time from the injection of radioisotopes to the final images of just 10 minutes, the 3D Mobile Gamma Camera is a powerful bedside decision-making tool useful even in the emergency room.
Market Dynamics: Drivers and Restraints
Rise in technological advancements
The rise in technological advancements is one of the significant key driver that helps the market to grow during the forecast period. The development of advanced gamma camera systems with improved imaging capabilities is driving the adoption of mobile gamma cameras.
For instance, in June 2023, Serac Imaging launched clinical testing of a portable gamma camera in the US. It is a portable high-resolution hybrid gamma optical camera developed by UK-based company Serac Imaging Systems and is now in clinical testing in the United States. In technology that was originally developed by the University of Leicester for satellites in X-ray astronomy, the device uses radiation to image radioisotopes, which are administered to the patient. This reveals information about the function of the body, for example, if there are blockages.
Some potential applications of the camera include bone, renal and infection imaging, lymphatic imaging, and sentinel lymph node localisation, as well as small organ imaging such as the thyroid.
Hence, the new pharmaceuticals open up new horizons, and we may be able to treat, even cure new diseases. With new cameras and better, quicker detectors, images are sharper, acquisitions are faster, and the radiation burden on patients is reduced. AI may prove to be an important aid to physicians. Furthermore, the global mobile gamma cameras market is also driven by various other factors like, a rise in the prevalence of chronic diseases, increasing adoption of mobile gamma cameras and others will further help the market during the forecast period.
Market Dynamics: Restraint
The introduction of new medical devices like mobile gamma cameras faces regulatory and reimbursement challenges, impacting their adoption and affordability. Also, cost constraints, such as high initial investment and ongoing maintenance, can hamper market accessibility, especially in resource-limited settings, affecting the adoption of these devices.
Segment Analysis
The global mobile gamma cameras market is segmented based on product type, indication, end user and region.
The triple mobile gamma cameras segment from the product type segment accounted for approximately 43.5% of the mobile gamma cameras market share
The triple mobile gamma cameras segment from the product type segment accounted for approximately 43.5% and is expected to be dominated during the forecast period. Among the type segment triple-head mobile gamma cameras are witnessing the fastest growth in the market due to the superior quality of the obtained images, high speed of the resolution of imagining, and cost-effectiveness. These cameras are majorly used for the brain and cardiac SPECT and among healthcare providers and patients the demand for these mobile gamma cameras is high owing to several benefits offered by them.
Also, Triple-head mobile gamma cameras provide higher imaging capabilities by concurrently using three detectors, resulting in improved picture quality, quicker imaging times, and increased patient productivity.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the high prevalence of chronic diseases, such as cancer and heart disease. The demand for diagnostic tools like mobile gamma cameras to detect and monitor these conditions continues to grow, as the population ages. Also, novel product launches, and ongoing advancements in mobile gamma camera technology, including improved image quality and reduced radiation exposure, are driving adoption in the country.
For instance, in May 2020, Digirad stated the launch of updated versions of its Ergo general-purpose nuclear camera and Cardius line of SPECT cameras. The upgraded cameras were developed throughout 2019 and are making their clinical debut this quarter in markets throughout the United States and Canada.
COVID-19 Impact Analysis
The novel coronavirus pandemic has resulted in a significant decline in the treatment of renal diseases worldwide. During the peak of the pandemic, there was a steep reduction in the number of patients with kidney failure accessing treatment such as transplants and dialysis. Such factors may have asserted a negative influence on the steady growth of the mobile gamma cameras industry over the past months.
Market Segmentation
By Product Type
• Triple Mobile Gamma Cameras
• Double Mobile Gamma Cameras
• Single Head Mobile Gamma Cameras
• Hand Held Mobile Gamma Cameras
By Indication
• Cardiac Imaging
• Breast Imaging
• Hepatobiliary Imaging
• GI Imaging
• Renal Imaging
• Brain Imaging
• Others
By End User
• Hospitals
• Ambulatory Surgical Centers
• Cancer Research Institutes
• Specialized Clinics
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Digirad Corporation, DDD-Diagnostic A/S, Spectrum Dynamics Medical, MIE America, LabLogic Systems Ltd, Crystal Photonics, Oncovision Inc, GAEDE Medizinsysteme GmbH, Mediso Ltd, GE Healthcare and among others.
Key Developments
 In May 2022, GE Healthcare announced the launch of its new mobile gamma camera, the Discovery NM/CT 570c. The Discovery NM/CT 570c is a hybrid mobile gamma camera that combines SPECT/CT imaging capabilities in a single device.
Why Purchase the Report?
• To visualize the global mobile gamma cameras market segmentation based on product type, indication, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of mobile gamma cameras market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global mobile gamma cameras market report would provide approximately 77 tables, 79 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Indication
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the technological advancements
4.1.1.2. Rise in the prevalence of chronic diseases
4.1.2. Restraints
4.1.2.1. Stringent regulatory approvals
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Triple Mobile Gamma Cameras*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Double Mobile Gamma Cameras
7.4. Single Head Mobile Gamma Cameras
7.5. Hand-Held Mobile Gamma Cameras
8. By Indication
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.1.2. Market Attractiveness Index, By Indication
8.2. Cardiac Imaging*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Breast Imaging
8.4. Hepatobiliary Imaging
8.5. GI Imaging
8.6. Renal Imaging
8.7. Brain Imaging
8.8. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Cancer Research Institutes
9.5. Specialized Clinics
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.5.1. China
10.5.5.2. India
10.5.5.3. Japan
10.5.5.4. Australia
10.5.5.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Digirad Corporation*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. DDD-Diagnostic A/S
12.3. Spectrum Dynamics Medical
12.4. MIE America
12.5. LabLogic Systems Ltd
12.6. Crystal Photonics
12.7. Oncovision Inc
12.8. GAEDE Medizinsysteme GmbH
12.9. Mediso Ltd
12.10. GE Healthcare
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Digirad Corporation, 4. Key Developments, DDD-Diagnostic A/S, Spectrum Dynamics Medical, MIE America, LabLogic Systems Ltd, Crystal Photonics, Oncovision Inc, GAEDE Medizinsysteme GmbH, Mediso Ltd, GE Healthcare

표 목록 (Tables)

List of Tables

Table 1 Global Mobile Gamma Cameras Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Mobile Gamma Cameras Market Value, By Indication, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Mobile Gamma Cameras Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Mobile Gamma Cameras Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Mobile Gamma Cameras Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Mobile Gamma Cameras Market Value, By Product Type, 2022-2031 (US$ Million)

Table 7 Global Mobile Gamma Cameras Market Value, By Indication, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Mobile Gamma Cameras Market Value, By Indication, 2022-2031 (US$ Million)

Table 9 Global Mobile Gamma Cameras Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Mobile Gamma Cameras Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Mobile Gamma Cameras Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Mobile Gamma Cameras Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Mobile Gamma Cameras Market Value, By Product Type, 2022-2031 (US$ Million)

Table 14 North America Mobile Gamma Cameras Market Value, By Indication, 2022-2031 (US$ Million)

Table 15 North America Mobile Gamma Cameras Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Mobile Gamma Cameras Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Mobile Gamma Cameras Market Value, By Product Type, 2022-2031 (US$ Million)

Table 18 South America Mobile Gamma Cameras Market Value, By Indication, 2022-2031 (US$ Million)

Table 19 South America Mobile Gamma Cameras Market Value, By End User, 2022-2031 (US$ Million)

Table 20 South America Mobile Gamma Cameras Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Mobile Gamma Cameras Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Europe Mobile Gamma Cameras Market Value, By Indication, 2022-2031 (US$ Million)

Table 23 Europe Mobile Gamma Cameras Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Mobile Gamma Cameras Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Mobile Gamma Cameras Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Mobile Gamma Cameras Market Value, By Indication, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Mobile Gamma Cameras Market Value, By End User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Mobile Gamma Cameras Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Mobile Gamma Cameras Market Value, By Product Type, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Mobile Gamma Cameras Market Value, By Indication, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Mobile Gamma Cameras Market Value, By End User, 2022-2031 (US$ Million)

Table 32 Digirad Corporation: Overview

Table 33 Digirad Corporation: Product Portfolio

Table 34 Digirad Corporation: Key Developments

Table 35 DDD-Diagnostic A/S: Overview

Table 36 DDD-Diagnostic A/S: Product Portfolio

Table 37 DDD-Diagnostic A/S: Key Developments

Table 38 Spectrum Dynamics Medical: Overview

Table 39 Spectrum Dynamics Medical: Product Portfolio

Table 40 Spectrum Dynamics Medical: Key Developments

Table 41 MIE America: Overview

Table 42 MIE America: Product Portfolio

Table 43 MIE America: Key Developments

Table 44 LabLogic Systems Ltd: Overview

Table 45 LabLogic Systems Ltd: Product Portfolio

Table 46 LabLogic Systems Ltd: Key Developments

Table 47 Crystal Photonics: Overview

Table 48 Crystal Photonics: Product Portfolio

Table 49 Crystal Photonics: Key Developments

Table 50 Oncovision Inc: Overview

Table 51 Oncovision Inc: Product Portfolio

Table 52 Oncovision Inc: Key Developments

Table 53 GAEDE Medizinsysteme GmbH: Overview

Table 54 GAEDE Medizinsysteme GmbH: Product Portfolio

Table 55 GAEDE Medizinsysteme GmbH: Key Developments

Table 56 Mediso Ltd: Overview

Table 57 Mediso Ltd: Product Portfolio

Table 58 Mediso Ltd: Key Developments

Table 59 GE Healthcare: Overview

Table 60 GE Healthcare: Product Portfolio

Table 61 GE Healthcare: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 2 Global Mobile Gamma Cameras Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Mobile Gamma Cameras Market Share, By Indication, 2022 & 2031 (%)

Figure 4 Global Mobile Gamma Cameras Market Share, By End User, 2022 & 2031 (%)

Figure 5 Global Mobile Gamma Cameras Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Mobile Gamma Cameras Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 7 Triple Mobile Gamma Cameras Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 8 Double Mobile Gamma Cameras Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 9 Single Head Mobile Gamma Cameras Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 10 Hand Held Mobile Gamma Cameras Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 11 Global Mobile Gamma Cameras Market Y-o-Y Growth, By Indication, 2022-2031 (%)

Figure 12 Cardiac Imaging Indication in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 13 Breast Imaging Indication in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 14 Hepatobiliary Imaging Indication in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 15 GI Imaging Indication in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 16 Renal Imaging Indication in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 17 Brain Imaging Indication in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 18 Others Indication in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 19 Global Mobile Gamma Cameras Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 20 Hospitals End User in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 21 Ambulatory Surgical Centers End User in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 22 Cancer Research Institutes End User in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 23 Specialized Clinics End User in Global Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 24 Global Mobile Gamma Cameras Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 25 North America Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 26 Asia-Pacific Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 27 Europe Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 28 South America Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 29 Middle East and Africa Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 30 North America Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 31 North America Mobile Gamma Cameras Market Share, By Product Type, 2022 & 2031 (%)

Figure 32 North America Mobile Gamma Cameras Market Share, By Indication, 2022 & 2031 (%)

Figure 33 North America Mobile Gamma Cameras Market Share, By End User, 2022 & 2031 (%)

Figure 34 North America Mobile Gamma Cameras Market Share, By Country, 2022 & 2031 (%)

Figure 35 South America Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 36 South America Mobile Gamma Cameras Market Share, By Product Type, 2022 & 2031 (%)

Figure 37 South America Mobile Gamma Cameras Market Share, By Indication, 2022 & 2031 (%)

Figure 38 South America Mobile Gamma Cameras Market Share, By End User, 2022 & 2031 (%)

Figure 39 South America Mobile Gamma Cameras Market Share, By Country, 2022 & 2031 (%)

Figure 40 Europe Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 41 Europe Mobile Gamma Cameras Market Share, By Product Type, 2022 & 2031 (%)

Figure 42 Europe Mobile Gamma Cameras Market Share, By Indication, 2022 & 2031 (%)

Figure 43 Europe Mobile Gamma Cameras Market Share, By End User, 2022 & 2031 (%)

Figure 44 Europe Mobile Gamma Cameras Market Share, By Country, 2022 & 2031 (%)

Figure 45 Asia-Pacific Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 46 Asia-Pacific Mobile Gamma Cameras Market Share, By Product Type, 2022 & 2031 (%)

Figure 47 Asia-Pacific Mobile Gamma Cameras Market Share, By Indication, 2022 & 2031 (%)

Figure 48 Asia-Pacific Mobile Gamma Cameras Market Share, By End User, 2022 & 2031 (%)

Figure 49 Asia-Pacific Mobile Gamma Cameras Market Share, By Country, 2022 & 2031 (%)

Figure 50 Middle East & Africa Mobile Gamma Cameras Market Value, 2022-2031 (US$ Million)

Figure 51 Middle East & Africa Mobile Gamma Cameras Market Share, By Product Type, 2022 & 2031 (%)

Figure 52 Middle East & Africa Mobile Gamma Cameras Market Share, By Indication, 2022 & 2031 (%)

Figure 53 Middle East & Africa Mobile Gamma Cameras Market Share, By End User, 2022 & 2031 (%)

Figure 54 Digirad Corporation: Financials

Figure 55 DDD-Diagnostic A/S: Financials

Figure 56 Spectrum Dynamics Medical: Financials

Figure 57 MIE America: Financials

Figure 58 LabLogic Systems Ltd: Financials

Figure 59 Crystal Photonics: Financials

Figure 60 Oncovision Inc: Financials

Figure 61 GAEDE Medizinsysteme GmbH: Financials

Figure 62 Mediso Ltd: Financials

Figure 63 GE Healthcare: Financials